Clinical trial
Effects of a Novel Carbohydrate Blocking Supplement on Glycemic Variability as Measured by Continuous Glucose Monitoring
NCT05832463 is registered in ClinicalTrials.gov with dōTERRA International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of a Novel Carbohydrate Blocking Supplement on Glycemic Variability as Measured by Continuous Glucose Monitoring
- Lead sponsor
- dōTERRA International
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 14, 2021
- Completion date
- July 15, 2022
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy